Weight-loss drugs are transforming both health care and Wall Street, with leading manufacturers like Eli Lilly & Co. (LLY) ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

Weight loss medications are often recommended for weight management in people with excess weight and obesity who are having a hard time seeing results with exercise and diet alone. If you haven ...

While weight-loss medications might aid in weight reduction, they can also disrupt hormone levels and ovulation. Long-term lifestyle changes, such as a balanced diet and regular exercise ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...